Pomdoctor Limited (POM)
| Market Cap | 583.92M |
| Revenue (ttm) | 46.93M |
| Net Income (ttm) | -19.64M |
| Shares Out | 118.44M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,804,808 |
| Open | 4.820 |
| Previous Close | 4.820 |
| Day's Range | 4.700 - 4.940 |
| 52-Week Range | 3.470 - 5.040 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About POM
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company’s business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other he... [Read more]
Financial Performance
In 2024, Pomdoctor's revenue was 342.56 million, an increase of 12.37% compared to the previous year's 304.85 million. Losses were -143.36 million, -1.40% less than in 2023.
Financial numbers in CNY Financial StatementsNews
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program
NEW YORK--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank, N.A., has been appointed by POMDOCTOR LIMITED (POM), a Chinese online medical services platform, as Depositary Bank for its Am...
U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown
Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government shutdo...
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
GUANGZHOU, China , Oct. 10, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announc...
PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules
The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
GUANGZHOU, China , Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announce...
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
GUANGZHOU, China , Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing ...
PomDoctor Files For Nasdaq IPO That May Be Overvalued
The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets
PomDoctor Begins $15 Million U.S. IPO Rollout
PomDoctor Limited is raising $15 million in an IPO to expand its telehealth platform in China. The telehealth sector is expected to grow substantially in the coming year in China. However, POM faces i...
Chinese online medical platform PomDoctor files for a $15 million US IPO
PomDoctor, an online platform in China offering chronic disease management services, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.
Pomdoctor IPO Registration Document (F-1)
Pomdoctor has filed to go public with an IPO on the NASDAQ.